Acadia Pharmaceuticals at AES 2026

Dec 4–8, 2026 Denver, CO ~6.2k attendees Website

Acadia Pharmaceuticals at AES 2026 in Denver: Booth 700.

OrganizationAES 2026 Attendance
acadia.com
Epilepsy drug and therapy developers
Neuroscience biopharma whose approved medicines treat Rett syndrome and Parkinson’s disease psychosis, with a pipeline for other rare neurological diseases.
Booth
Exhibiting at Booth 700
Sat, Dec 511:45am–5:30pmSun, Dec 610:00am–4:00pmMon, Dec 710:00am–2:00pm
Exhibit floor office O3022

Explore the full AES 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Denver. Leave your work email and we’ll be in touch.

Privacy

Download the full AES 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Acadia Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the American Epilepsy Society. Organization details are derived from AES’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction